Skip to main content

Table 2 Reactivity with CD30 negative cell lines

From: Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas

Cell Line

Isotype Control

BerH2

R23.1

R24.1

U937

-

-

-

-

Jurkat (T acute lymphoblastic leukemia

-

-

-

-

HL60

-

-

-

-

Raji (Burkitt lymphoma)

-

-

-

-

Daudi (Burkitt lymphoma)

-

-

-

-

OCI Ly7 (Large B cell lymphoma)

-

-

-

-

OCI Ly18 (Large B cell lymphoma)

-

-

-

-

OCI M2 (Erythroleukemia)

-

-

-

-

AML-2 (Acute myeloid leukemia)

-

-

-

-

AML-4 (Acute myeloid leukemia)

-

-

-

-

OCI Ly13.1 (Peripheral T cell lymphoma)

-

-

-

-

OCI Ly13.2 (Peripheral T cell lymphoma)

-

-

-

-

OCI Ly8 (B Immunoblastic lymphoma)

-

-

-

-

OCI Ly2 (Large B cell lymphoma)

-

-

-

-